Journal
BMC CANCER
Volume 22, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s12885-022-10149-7
Keywords
Familial clustering; Multiple primary cancer; Cumulative incidence; Relative risk
Categories
Funding
- Lund University
- Swedish Research Council [2021-01187, 2018-02400, 2020-01175]
- Cancerfonden [CAN2017/340]
- Crafoordska Stiftelsen
- MAS Cancer
- ALF funding from Region Skane
- Swedish Research Council [2021-01187] Funding Source: Swedish Research Council
Ask authors/readers for more resources
This study found that the risk of lung cancer (LCa) is similar when a first-degree relative (FDR) is diagnosed with either LCa-1 or LCa-2. The risk is higher when the FDR is diagnosed with LCa-2 within a certain period of time after the first primary cancer. The risk of LCa is also increased for certain types of first primary cancers, such as ovarian, nervous system, upper aerodigestive tract, cervix, and non-Hodgkin lymphoma.
Background Aggregation of lung cancer (LCa) in family members is well-documented. However, little is known on the familial risk of LCa when first-degree relatives (FDRs, parents or siblings) are diagnosed with LCa as a second primary malignancy (LCa-2). We aimed to investigate whether and to what extent a family history of LCa-2 was associated with an increased LCa risk. Methods In this Swedish national cohort we identified 127,865 individuals who had one FDR affected by LCa as a first primary cancer (LCa-1) and 15,490 individuals who had one FDR affected by LCa-2, respectively. We then estimated relative risk (RR) of LCa using those without cancer family history as reference. Results The number of LCa-2 has been increasing annually and rather similarly in men and women in the last decade. Familial RR of LCa was 1.96 (95%, 1.85-2.07) for LCa-1 family history and 1.89 for LCa-2 (1.62-2.21). Risk was especially high when FDR was diagnosed with early-onset LCa-2 and when siblings were affected by LCa-2. The RR was 1.53 (1.10-2.12) when LCa-2 in FDR was diagnosed within 26 months after first primary cancer, and it increased to 2.16 (1.62-2.90) when LCa-2 was diagnosed between 74 to 154 months. Higher risk was observed for first primary cancer of the ovary (4.45, 1.85-10.7), nervous system (3.49, 1.45-8.38), upper aerodigestive tract (2.83, 1.78-4.49) and cervix (2.55, 1.41-4.61), and for non-Hodgkin lymphoma (3.13, 1.57-6.27). Conclusions LCa risk is associated with diagnosis of LCa-2 in FDR to a similar degree as LCa-1 in FDRs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available